Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial
AbstractObjectivesThe hypothesis of the proposed intervention is that Granulocyte-macrophage colony-stimulating factor (GM-CSF) has profound effects on antiviral immunity, and can provide the stimulus to restore immune homeostasis in the lung with acute lung injury post COVID-19, and can promote lung repair mechanisms, that lead to a 25% improvement in lung oxygenation parameters. Sargramostim is a man-made form of the naturally-occurring protein GM-CSF.Trial designA phase 4 academic, prospective, 2 arm (1:1 ratio), randomized, open-label, controlled trial.ParticipantsPatients aged 18-80 years admitted to specialized COVID...
Source: Trials - June 4, 2020 Category: Research Source Type: clinical trials
Do We Need to Taper Down Steroid Therapy for Bell's Palsy
Condition: Bell Palsy Intervention: Drug: Prednisone tablet Sponsor: Carmel Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2020 Category: Research Source Type: clinical trials
